467 related articles for article (PubMed ID: 19374962)
1. Remission in schizophrenia: analysis in a naturalistic setting.
Eberhard J; Levander S; Lindström E
Compr Psychiatry; 2009; 50(3):200-8. PubMed ID: 19374962
[TBL] [Abstract][Full Text] [Related]
2. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
3. Patient-based and clinician-based support for the remission criteria in schizophrenia.
Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
[TBL] [Abstract][Full Text] [Related]
4. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
[TBL] [Abstract][Full Text] [Related]
5. Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.
Alenius M; Hammarlund-Udenaes M; Hartvig P; Sundquist S; Lindström L
Compr Psychiatry; 2009; 50(5):453-62. PubMed ID: 19683616
[TBL] [Abstract][Full Text] [Related]
6. Psychotic symptoms in patients with bipolar mania.
Canuso CM; Bossie CA; Zhu Y; Youssef E; Dunner DL
J Affect Disord; 2008 Dec; 111(2-3):164-9. PubMed ID: 18378001
[TBL] [Abstract][Full Text] [Related]
7. Achieving symptomatic remission in out-patients with schizophrenia--a naturalistic study with quetiapine.
Wobrock T; Köhler J; Klein P; Falkai P
Acta Psychiatr Scand; 2009 Aug; 120(2):120-8. PubMed ID: 19392812
[TBL] [Abstract][Full Text] [Related]
8. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
[TBL] [Abstract][Full Text] [Related]
9. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Int Clin Psychopharmacol; 2008 Nov; 23(6):325-31. PubMed ID: 18854720
[TBL] [Abstract][Full Text] [Related]
10. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
[TBL] [Abstract][Full Text] [Related]
12. One-year outcome and its prediction in first-episode schizophrenia--a naturalistic study.
Bachmann S; Bottmer C; Schroder J
Psychopathology; 2008; 41(2):115-23. PubMed ID: 18059113
[TBL] [Abstract][Full Text] [Related]
13. Influence of novel and conventional antipsychotic medication on subjective quality of life.
Tempier R; Pawliuk N
J Psychiatry Neurosci; 2001 Mar; 26(2):131-6. PubMed ID: 11291530
[TBL] [Abstract][Full Text] [Related]
14. [Factors connected with the effect of risperidone on psychopathological symptoms and working memory in schizophrenia].
Borkowska A; Rybakowski J
Psychiatr Pol; 2002; 36(6 Suppl):225-33. PubMed ID: 12647443
[TBL] [Abstract][Full Text] [Related]
15. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
[TBL] [Abstract][Full Text] [Related]
16. Classifying episodes in schizophrenia and bipolar disorder: criteria for relapse and remission applied to recent-onset samples.
Nuechterlein KH; Miklowitz DJ; Ventura J; Gitlin MJ; Stoddard M; Lukoff D
Psychiatry Res; 2006 Nov; 144(2-3):153-66. PubMed ID: 17011635
[TBL] [Abstract][Full Text] [Related]
17. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
[TBL] [Abstract][Full Text] [Related]
18. Nicotine use and its correlates in patients with psychosis.
Levander S; Eberhard J; Lindström E
Acta Psychiatr Scand Suppl; 2007; (435):27-32. PubMed ID: 17953523
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome.
Lindström E; Eberhard J; Levander S
Acta Psychiatr Scand Suppl; 2007; (435):5-16. PubMed ID: 17953521
[TBL] [Abstract][Full Text] [Related]
20. Weight development in patients treated with risperidone: a 5-year naturalistic study.
Neovius M; Eberhard J; Lindström E; Levander S
Acta Psychiatr Scand; 2007 Apr; 115(4):277-85. PubMed ID: 17355518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
